Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bush

Showing results (501-510 of 517) with videos related to

Pageof 52
Sort By:
Journal of Alzheimer'S Disease : JAD|November 25, 2017
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay PlatformsJames D Doecke, Alan Rembach, Victor L Villemagne, et al.
Nature Reviews. Cancer|November 12, 2021
Connecting copper and cancer: from transition metal signalling to metalloplasiaEva J Ge, Ashley I Bush, Angela Casini, et al.
Nature Communications|November 11, 2020
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's diseaseKevin Huynh, Wei Ling Florence Lim, Corey Giles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's diseaseAlan Rembach, Noel G Faux, Andrew D Watt, et al.
Cell|October 7, 2017
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and DiseaseBrent R Stockwell, José Pedro Friedmann Angeli, Hülya Bayir, et al.
Archives of Neurology|July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseJames D Doecke, Simon M Laws, Noel G Faux, et al.
The Journal of Experimental Medicine|April 5, 2012
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's diseaseLin W Hung, Victor L Villemagne, Lesley Cheng, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of agingJames K Lui, Simon M Laws, Qiao-Xin Li, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 16, 2017
Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient careYi Wang, Pascal Spincemaille, Zhe Liu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2022
APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studiesTingting Wang, Kevin Huynh, Corey Giles, et al.
Pageof 52

Showing results (501-510 of 517) with videos related to

Sort By:
Pageof 52
Journal of Alzheimer'S Disease : JAD|November 25, 2017
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay PlatformsJames D Doecke, Alan Rembach, Victor L Villemagne, et al.
Nature Reviews. Cancer|November 12, 2021
Connecting copper and cancer: from transition metal signalling to metalloplasiaEva J Ge, Ashley I Bush, Angela Casini, et al.
Nature Communications|November 11, 2020
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's diseaseKevin Huynh, Wei Ling Florence Lim, Corey Giles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's diseaseAlan Rembach, Noel G Faux, Andrew D Watt, et al.
Cell|October 7, 2017
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and DiseaseBrent R Stockwell, José Pedro Friedmann Angeli, Hülya Bayir, et al.
Archives of Neurology|July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseJames D Doecke, Simon M Laws, Noel G Faux, et al.
The Journal of Experimental Medicine|April 5, 2012
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's diseaseLin W Hung, Victor L Villemagne, Lesley Cheng, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of agingJames K Lui, Simon M Laws, Qiao-Xin Li, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 16, 2017
Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient careYi Wang, Pascal Spincemaille, Zhe Liu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2022
APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studiesTingting Wang, Kevin Huynh, Corey Giles, et al.
Pageof 52